MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to vir bio
-$437,987K
(16.09%↑ Y/Y)
Net loss
-$437,987K
(16.09%↑ Y/Y)
Interest income
$40,238K
(-43.97%↓ Y/Y)
Change in fair value of
equity investments
$1,729K
(131.28%↑ Y/Y)
Loss before
(provision for) benefit...
-$437,770K
(16.31%↑ Y/Y)
(provision for) benefit
from income taxes
$217K
(118.95%↑ Y/Y)
Total other income
$41,558K
(-35.13%↓ Y/Y)
License And
Collaboration Revenue
$63,130K
Other Revenue
$3,390K
Grant
$2,036K
Other expense, net
-$409K
(81.58%↑ Y/Y)
Loss from operations
-$479,328K
(18.37%↑ Y/Y)
Total revenues
$68,556K
(7.60%↑ Y/Y)
Total operating
expenses
$547,884K
(-17.16%↓ Y/Y)
Restructuring, long-lived
assets impairment and...
-$182K
(-100.52%↓ Y/Y)
Research and development
$455,966K
(-9.98%↓ Y/Y)
Selling, general and
administrative
$92,074K
(-22.65%↓ Y/Y)
Cost of revenue
$26K
(-96.92%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Vir Biotechnology, Inc. (VIR)
Vir Biotechnology, Inc. (VIR)